908 Devices (MASS) CEO awarded RSUs, options and sells shares for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
908 Devices Inc. President and CEO Kevin J. Knopp reported equity compensation activity and a tax-related share sale. On February 1, 2026, several Restricted Stock Units vested and were settled for 11,255, 13,449, 17,007, and 66,288 shares of common stock, increasing his direct holdings to 830,732 shares.
On February 2, 2026, Knopp sold 34,764 shares of common stock at a weighted average price of $6.18 solely to cover tax withholding from the RSU vesting, leaving 795,968 shares held directly. He also received 205,978 new RSUs and a stock option for 90,043 shares at a $6.19 exercise price, which begin vesting on February 1, 2027. Separately, 541,223 shares are held indirectly by The Kevin J. Knopp Irrevocable Trust of 2018, for which his brother-in-law serves as trustee with sole voting and dispositive control.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 34,764 shares ($214,842)
Net Sell
12 txns
Insider
Knopp Kevin J.
Role
President and CEO
Sold
34,764 shs ($215K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 205,978 | $0.00 | -- |
| Grant/Award | Stock Option (option to buy) | 90,043 | $0.00 | -- |
| Sale | Common Stock | 34,764 | $6.18 | $215K |
| Exercise | Restricted Stock Units | 11,255 | $0.00 | -- |
| Exercise | Restricted Stock Units | 13,449 | $0.00 | -- |
| Exercise | Restricted Stock Units | 17,007 | $0.00 | -- |
| Exercise | Restricted Stock Units | 66,288 | $0.00 | -- |
| Exercise | Common Stock | 11,255 | $0.00 | -- |
| Exercise | Common Stock | 13,449 | $0.00 | -- |
| Exercise | Common Stock | 17,007 | $0.00 | -- |
| Exercise | Common Stock | 66,288 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 205,978 shares (Direct);
Stock Option (option to buy) — 90,043 shares (Direct);
Common Stock — 795,968 shares (Direct);
Common Stock — 541,223 shares (Indirect, See footnote)
Footnotes (1)
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.105 to $6.32, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The shares are owned directly by The Kevin J. Knopp Irrevocable Trust of 2018. The reporting person's brother-in-law is the trustee of The Kevin J. Knopp Irrevocable Trust of 2018 and has sole voting and dispositive control with respect to all securities held by such trust. The reporting person may be deemed to be the beneficial owner of the securities held by The Kevin J. Knopp Irrevocable Trust of 2018. These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2022, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. The RSUs shall vest one-third on February 1, 2026, with the remaining two-thirds vesting in two substantially equal annual installments at the two anniversary dates following February 1, 2026, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. The RSUs shall vest one-third on February 1, 2027, with the remaining two-thirds vesting in two substantially equal annual installments at the two anniversary dates following February 1, 2027, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. One-third of the shares underlying the option become vested and exercisable on February 1, 2027, and the remaining two-thirds of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 24 months following February 1, 2027, subject to the reporting person's continued service through the applicable vesting date.
FAQ
What did 908 Devices (MASS) CEO Kevin Knopp report in this Form 4 filing?
Kevin Knopp reported RSU vesting, a tax-related sale, and new equity awards. Several RSU grants converted into common stock, some shares were sold to cover withholding taxes, and he received additional RSUs and a stock option that vest over future years.
What new equity awards did 908 Devices (MASS) grant to its CEO?
The CEO received 205,978 new Restricted Stock Units and a stock option covering 90,043 shares at a $6.19 exercise price. The RSUs and option begin vesting on February 1, 2027, with remaining portions vesting over the following two years, subject to continued service.
What indirect ownership does the 908 Devices (MASS) CEO have through a trust?
The filing shows 541,223 shares of 908 Devices common stock held indirectly by The Kevin J. Knopp Irrevocable Trust of 2018. Knopp’s brother-in-law is trustee with sole voting and dispositive control, and Knopp may be deemed a beneficial owner of those trust-held securities.
How do the CEO’s Restricted Stock Units in 908 Devices (MASS) vest over time?
Certain RSU grants vest in four equal annual installments following grant dates in 2022, 2023, and 2024. New RSUs granted in 2026 and 2027 vest one-third on February 1, 2026 or 2027, with the remaining two-thirds vesting in two equal annual installments, subject to continued service.